Global Influenza Vaccine Market | Market Research Report

The Global Influenza Vaccine Market to grow from USD 5,563.37 Million in 2019 to USD 7,321.79 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.68%. Some of the major market players include Abbott Biologicals B.V., AstraZeneca, BioDiem, BiondVax Pharmaceuticals Ltd., and Daiichi-Sankyo.

360iResearch Logo
Global Influenza Vaccine Market
Report Code: MRR-7D913F0 | Publishing Date: | Number of Pages: 164
Global Influenza Vaccine Market | Market Research Report

Market Dynamics:

The factors attributing to the growth of the market are increasing prevalence of respiratory disorders, clinical trials and vaccines developments in pipeline for seasonal influenzas, immunization as a major public health measure for the prevention of influenza virus infection, and government initiatives supporting respiratory health. However, some factors such as lack of inadequate delivery infrastructure & limited awareness may hinder the market growth. The Influenza Vaccine Market is expected to showcase the opportunities such as several vaccine candidates under development against animal influenza a viruses, increasing r&d expenditure by leading companies, and increase vaccine availability through reselling collaborations. In the near future market may face the possible challenges in the growth due to continues changes in strains challenges vaccine research and development and consumer trust & confidence in respiratory disease vaccination. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Influenza Vaccine Market.

Global Influenza Vaccine Market: Market Dynamics
Global Influenza Vaccine Market: Market Dynamics

Market Segmentation & Coverage:

The research report categorizes the Influenza Vaccine Market to forecast the revenues and analyze the trends in each of the following segments:

On the basis of Age Group, the Influenza Vaccine Market is studied across Adolescent Vaccination, Adult Vaccination, and Infant Vaccination.

On the basis of Vaccine Type, the Influenza Vaccine Market is studied across Inactivated, Live Attenuated, and Recombinant.

On the basis of Administration Rout, the Influenza Vaccine Market is studied across Intramuscular and Intranasal.

On the basis of Distribution Channel, the Influenza Vaccine Market is studied across Hospital & Clinic, Medical Office, Retail Pharmacy, and Urgent Care Unit.

On the basis of Geography, the Influenza Vaccine Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa.

Competitive News Feed Analysis:

The research report closely tracks the resent developments by the dominating players and innovation profiles in the market including:

  • Emergent BioSolutions to Manufacture Oral Vaccine and Develop Antibody Therapeutics for COVID-19 (2020-03-20)
  • PFIZER ANNOUNCES TOP-LINE RESULTS FROM PHASE 3 STUDY OF 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PNEUMOCOCCAL VACCINE-NAÏVE ADULTS AGED 18 YEARS OR OLDER (2020-03-18)
  • Vaxart Announces It Entered Into An Agreement With Emergent Biosolutions For The Development And Manufacturing Of Oral Coronavirus (Covid-19) Vaccine (2020-03-18)

Company Usability Profiles:

The Influenza Vaccine Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The Influenza Vaccine Market research report provides the company usability profiles and analyze the overview, strategy, SWOT and scorecard of the following company:

  • Abbott Biologicals B.V.
  • AstraZeneca
  • BioDiem
  • BiondVax Pharmaceuticals Ltd.
  • Daiichi-Sankyo
  • Emergent BioSolutions
  • Fluart Innovative Vaccines Kft.
  • GAMMA VACCINES PTY LTD.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Mylan N.V.
  • Pfizer Inc.
  • Sanofi S.A.
  • Seqirus GmbH
  • Serum Institute of India Private Limited

Scope of the Report:

AttributeDetails
Base Year for Estimation2019
Historical Period2017 - 2018
Estimation Period2020 - 2021
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Influenza Vaccine Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Influenza Vaccine Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Influenza Vaccine Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Influenza Vaccine Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Influenza Vaccine Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Influenza Vaccine Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Influenza Vaccine Market .
  • Evaluate the key vendors in the Influenza Vaccine Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research & Forecasting
    1. Research Methodology
    2. Forecasting Methodology
  3. Executive Summary
    1. Market Outlook
    2. Geography Outlook
    3. Competitor Outlook
  4. Market Overview
    1. Introduction
    2. Influenza Vaccine Market, By Geography
    3. Influenza Vaccine Market, By Age Group
    4. Influenza Vaccine Market, By Vaccine Type
    5. Influenza Vaccine Market, By Administration Rout
    6. Influenza Vaccine Market, By Distribution Channel
  5. Market Dynamics
    1. Introduction
    2. Drivers
      1. Increasing prevalence of respiratory disorders
      2. Immunization as a major public health measure for the prevention of influenza virus infection
      3. Clinical trials and vaccines developments in pipeline for seasonal influenzas
      4. Government initiatives supporting respiratory health
    3. Restraints
      1. Lack of inadequate delivery infrastructure & limited awareness
    4. Opportunities
      1. Increasing R&D expenditure by leading companies
      2. Increase vaccine availability through reselling collaborations
      3. Several vaccine candidates under development against animal influenza A viruses
    5. Challenges
      1. Consumer trust & confidence in respiratory disease vaccination
      2. Continues changes in strains challenges vaccine research and development
  6. Industry Trends
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Client Customizations
      1. COVID: Eye on Proactive Vaccine Development
      2. Shift to Retail Pharmacies for Immunizations
  7. Influenza Vaccine Market, By Age Group
    1. Introduction
    2. Adolescent Vaccination
    3. Adult Vaccination
    4. Infant Vaccination
  8. Influenza Vaccine Market, By Vaccine Type
    1. Introduction
    2. Inactivated
    3. Live Attenuated
    4. Recombinant
  9. Influenza Vaccine Market, By Administration Rout
    1. Introduction
    2. Intramuscular
    3. Intranasal
  10. Influenza Vaccine Market, By Distribution Channel
    1. Introduction
    2. Hospital & Clinic
    3. Medical Office
    4. Retail Pharmacy
    5. Urgent Care Unit
  11. Influenza Vaccine Market, By Americas
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  12. Influenza Vaccine Market, By Asia-Pacific
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. South Korea
    10. Thailand
  13. Influenza Vaccine Market, By Europe, Middle East & Africa
    1. Introduction
    2. France
    3. Germany
    4. Italy
    5. Netherlands
    6. Qatar
    7. Russia
    8. Saudi Arabia
    9. South Africa
    10. Spain
    11. United Arab Emirates
    12. United Kingdom
  14. Competitive Landscape
    1. FPNV Positioning Matrix
    2. Market Vendor Ranking Analysis
    3. Competitive News Feed Analysis
  15. Company Usability Profiles
    1. Abbott Biologicals B.V.
      1. Overview
      2. Key Takeaways
      3. Recommendations
    2. AstraZeneca
      1. Overview
      2. Key Takeaways
      3. Recommendations
    3. BioDiem
      1. Overview
      2. Key Takeaways
      3. Recommendations
    4. BiondVax Pharmaceuticals Ltd.
      1. Overview
      2. Key Takeaways
      3. Recommendations
    5. Daiichi-Sankyo
      1. Overview
      2. Key Takeaways
      3. Recommendations
    6. Emergent BioSolutions
      1. Overview
      2. Key Takeaways
      3. Recommendations
    7. Fluart Innovative Vaccines Kft.
      1. Overview
      2. Key Takeaways
      3. Recommendations
    8. GAMMA VACCINES PTY LTD.
      1. Overview
      2. Key Takeaways
      3. Recommendations
    9. GlaxoSmithKline plc
      1. Overview
      2. Key Takeaways
      3. Recommendations
    10. Merck & Co., Inc.
      1. Overview
      2. Key Takeaways
      3. Recommendations
    11. Mylan N.V.
      1. Overview
      2. Key Takeaways
      3. Recommendations
    12. Pfizer Inc.
      1. Overview
      2. Key Takeaways
      3. Recommendations
    13. Sanofi S.A.
      1. Overview
      2. Key Takeaways
      3. Recommendations
    14. Seqirus GmbH
      1. Overview
      2. Key Takeaways
      3. Recommendations
    15. Serum Institute of India Private Limited
      1. Overview
      2. Key Takeaways
      3. Recommendations
  16. Appendix
    1. Discussion Guide
    2. Edition Details
    3. License Details
    4. Pricing Details

List of Tables

  1. GLOBAL INFLUENZA VACCINE MARKET: SEGMENTATION & COVERAGE
  2. GLOBAL INFLUENZA VACCINE MARKET SIZE, 2017-2025 (USD MILLION)
  3. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  4. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  5. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADULT VACCINATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  6. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INFANT VACCINATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  7. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  8. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INACTIVATED, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  9. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  10. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RECOMBINANT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  11. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  12. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  13. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRANASAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  14. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  15. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITAL & CLINIC, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  16. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY MEDICAL OFFICE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  17. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  18. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY URGENT CARE UNIT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  19. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLION)
  20. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  21. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  22. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  23. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  24. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  25. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  26. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  27. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  28. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  29. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  30. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  31. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  32. CANADA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  33. CANADA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  34. CANADA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  35. CANADA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  36. MEXICO INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  37. MEXICO INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  38. MEXICO INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  39. MEXICO INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  40. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  41. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  42. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  43. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  44. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLION)
  45. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  46. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  47. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  48. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  49. AUSTRALIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  50. AUSTRALIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  51. AUSTRALIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  52. AUSTRALIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  53. CHINA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  54. CHINA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  55. CHINA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  56. CHINA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  57. INDIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  58. INDIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  59. INDIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  60. INDIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  61. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  62. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  63. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  64. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  65. JAPAN INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  66. JAPAN INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  67. JAPAN INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  68. JAPAN INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  69. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  70. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  71. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  72. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  73. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  74. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  75. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  76. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  77. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  78. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  79. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  80. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  81. THAILAND INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  82. THAILAND INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  83. THAILAND INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  84. THAILAND INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  85. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLION)
  86. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  87. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  88. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  89. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  90. FRANCE INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  91. FRANCE INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  92. FRANCE INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  93. FRANCE INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  94. GERMANY INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  95. GERMANY INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  96. GERMANY INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  97. GERMANY INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  98. ITALY INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  99. ITALY INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  100. ITALY INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  101. ITALY INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  102. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  103. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  104. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  105. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  106. QATAR INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  107. QATAR INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  108. QATAR INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  109. QATAR INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  110. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  111. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  112. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  113. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  114. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  115. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  116. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  117. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  118. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  119. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  120. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  121. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  122. SPAIN INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  123. SPAIN INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  124. SPAIN INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  125. SPAIN INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  126. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  127. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  128. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  129. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  130. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
  131. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  132. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
  133. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  134. GLOBAL INFLUENZA VACCINE MARKET: RANKING
  135. GLOBAL INFLUENZA VACCINE MARKET: BUSINESS STRATEGY
  136. GLOBAL INFLUENZA VACCINE MARKET: PRODUCT SATISFACTION
  137. COMPETITIVE NEWS FEED ANALYSIS FOR ABBOTT BIOLOGICALS B.V.
  138. COMPETITIVE NEWS FEED ANALYSIS FOR ASTRAZENECA
  139. COMPETITIVE NEWS FEED ANALYSIS FOR BIODIEM
  140. COMPETITIVE NEWS FEED ANALYSIS FOR BIONDVAX PHARMACEUTICALS LTD.
  141. COMPETITIVE NEWS FEED ANALYSIS FOR DAIICHI-SANKYO
  142. COMPETITIVE NEWS FEED ANALYSIS FOR EMERGENT BIOSOLUTIONS
  143. COMPETITIVE NEWS FEED ANALYSIS FOR GAMMA VACCINES PTY LTD.
  144. COMPETITIVE NEWS FEED ANALYSIS FOR GLAXOSMITHKLINE PLC
  145. COMPETITIVE NEWS FEED ANALYSIS FOR MERCK & CO., INC.
  146. COMPETITIVE NEWS FEED ANALYSIS FOR PFIZER INC.
  147. COMPETITIVE NEWS FEED ANALYSIS FOR SANOFI S.A.
  148. COMPETITIVE NEWS FEED ANALYSIS FOR SEQIRUS GMBH
  149. GLOBAL INFLUENZA VACCINE MARKET: EDITION DETAILS
  150. GLOBAL INFLUENZA VACCINE MARKET: LICENSE DETAILS
  151. GLOBAL INFLUENZA VACCINE MARKET: PRICING DETAILS

List of Figures

  1. GLOBAL INFLUENZA VACCINE MARKET: RESEARCH PROCESS
  2. GLOBAL INFLUENZA VACCINE MARKET: RESEARCH FRAMEWORK
  3. GLOBAL INFLUENZA VACCINE MARKET: FORECASTING METHODOLOGY
  4. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  5. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL INFLUENZA VACCINE MARKET, BY NEWS TYPE
  6. GLOBAL INFLUENZA VACCINE MARKET SIZE, 2017-2025 (USD MILLION)
  7. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  8. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2019 VS 2025 (USD MILLION)
  9. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2019 VS 2025 (USD MILLION)
  10. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2019 VS 2025 (USD MILLION)
  11. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (USD MILLION)
  12. GLOBAL INFLUENZA VACCINE MARKET: MARKET DYNAMICS
  13. GLOBAL INFLUENZA VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
  14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025 (USD MILLION)
  15. GLOBAL INFLUENZA VACCINE MARKET, BY ADOLESCENT VACCINATION SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  16. GLOBAL INFLUENZA VACCINE MARKET, BY ADULT VACCINATION SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  17. GLOBAL INFLUENZA VACCINE MARKET, BY INFANT VACCINATION SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025 (USD MILLION)
  19. GLOBAL INFLUENZA VACCINE MARKET, BY INACTIVATED SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  20. GLOBAL INFLUENZA VACCINE MARKET, BY LIVE ATTENUATED SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  21. GLOBAL INFLUENZA VACCINE MARKET, BY RECOMBINANT SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2025 (USD MILLION)
  23. GLOBAL INFLUENZA VACCINE MARKET, BY INTRAMUSCULAR SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  24. GLOBAL INFLUENZA VACCINE MARKET, BY INTRANASAL SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 (USD MILLION)
  26. GLOBAL INFLUENZA VACCINE MARKET, BY HOSPITAL & CLINIC SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  27. GLOBAL INFLUENZA VACCINE MARKET, BY MEDICAL OFFICE SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  28. GLOBAL INFLUENZA VACCINE MARKET, BY RETAIL PHARMACY SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  29. GLOBAL INFLUENZA VACCINE MARKET, BY URGENT CARE UNIT SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  30. GLOBAL INFLUENZA VACCINE MARKET: FPNV POSITIONING MATRIX
  31. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL INFLUENZA VACCINE MARKET, BY COMPANY
  32. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL INFLUENZA VACCINE MARKET, BY YEAR
  1. Abbott Biologicals B.V.
  2. AstraZeneca
  3. BioDiem
  4. BiondVax Pharmaceuticals Ltd.
  5. Daiichi-Sankyo
  6. Emergent BioSolutions
  7. Fluart Innovative Vaccines Kft.
  8. GAMMA VACCINES PTY LTD.
  9. GlaxoSmithKline plc
  10. Merck & Co., Inc.
  11. Mylan N.V.
  12. Pfizer Inc.
  13. Sanofi S.A.
  14. Seqirus GmbH
  15. Serum Institute of India Private Limited
Global Influenza Vaccine Market
Report Code
MRR-7D913F0
Publishing Date
March 2020
Number of Pages
164
Available Formats

SELECT LICENSE TYPE

ENTERPRISE USER LICENSE $9449
CORPORATE USER LICENSE $7449
SINGLE USER LICENSE $5449

Trusted by 2,000+ Companies Worldwide

Here's what some of our customers say about our work.
We appreciate all of our customers' testimonials.